Paper8137239
Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2.
Kharbanda S and 5 others. Cancer Res, 1994. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2. Papers, record 8137239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8137239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CDC2 Protein Kinase | Major topic |
| Tyrosine | Major topic |
| Humans | |
| Leukemia, Myeloid | |
| Neoplasm Proteins | |
| Phosphorylation | |
| Precipitin Tests | |
| Protein Kinases | |
| Protein Processing, Post-Translational | |
| Radiation, Ionizing | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA55241 | NCI NIH HHS | United States | PubMed |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35328212 | Cell Signaling Pathways That Promote Radioresistance of Cancer Cells. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35328212 | PubMed |
| 28249796 | Biological determinants of radioresistance and their remediation in pancreatic cancer. | Biochim Biophys Acta Rev Cancer | 2017 | https://conductscience.org/library/papers/28249796 | PubMed |
| 27621574 | Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/27621574 | PubMed |
| 25344910 | Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. | Oncotarget | 2014 | https://conductscience.org/library/papers/25344910 | PubMed |
| 25174607 | Radiation-induced signaling pathways that promote cancer cell survival (review). | Int J Oncol | 2014 | https://conductscience.org/library/papers/25174607 | PubMed |
| 24909175 | A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation. | Oncogene | 2015 | https://conductscience.org/library/papers/24909175 | PubMed |
| 23166842 | ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation. | PLoS One | 2012 | https://conductscience.org/library/papers/23166842 | PubMed |
| 22494620 | RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation. | Breast Cancer Res | 2012 | https://conductscience.org/library/papers/22494620 | PubMed |
| 17297454 | Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. | Oncogene | 2007 | https://conductscience.org/library/papers/17297454 | PubMed |
| 16632889 | Control of the G2/M transition. | Mol Biotechnol | 2006 | https://conductscience.org/library/papers/16632889 | PubMed |
| 15735702 | BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation. | Oncogene | 2005 | https://conductscience.org/library/papers/15735702 | PubMed |
| 10713160 | Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10713160 | PubMed |
| 9841670 | Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae. | Microbiol Mol Biol Rev | 1998 | https://conductscience.org/library/papers/9841670 | PubMed |
| 9722613 | Entry into mitosis in vertebrate somatic cells is guarded by a chromosome damage checkpoint that reverses the cell cycle when triggered during early but not late prophase. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9722613 | PubMed |
| 9585407 | Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9585407 | PubMed |
| 9034337 | Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. | EMBO J | 1997 | https://conductscience.org/library/papers/9034337 | PubMed |
| 9009279 | The G2/M DNA damage checkpoint inhibits mitosis through Tyr15 phosphorylation of p34cdc2 in Aspergillus nidulans. | EMBO J | 1997 | https://conductscience.org/library/papers/9009279 | PubMed |
| 8769420 | Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. | J Cell Biol | 1996 | https://conductscience.org/library/papers/8769420 | PubMed |
| 7554031 | Apoptosis, cancer and the p53 tumour suppressor gene. | Cancer Metastasis Rev | 1995 | https://conductscience.org/library/papers/7554031 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CDK1 | 983 | PubTator's text mining | https://conductscience.org/library/genes/983 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8137239
GET https://conductscience.org/api/papers/v1/8137239/authors